Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07532603 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

Study acronym: ALPINE
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 5 → 61 locationsv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
Trial Details
NCT Number NCT07532603
Lead Sponsor Priovant Therapeutics, Inc.
Conditions
(from sponsor)		 Lichen Planopilaris
Related terms Lichen Planus
Enrollment 342 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov